The complex between urokinase-type plasminogen activator (uPA) and its type-I inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Bibliographic Details
Title: The complex between urokinase-type plasminogen activator (uPA) and its type-I inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer
Authors: Manders, P., Tjan-Heijnen, V. C. G., Span, P. N., Grebenchtchikov, N., Geurts-Moespot, A. J., van Tienoven, D. T. H., Beex, L. V. A. M., Sweep, F. C. G. J.
Source: THROMBOSIS AND HAEMOSTASIS -STUTTGART-. 91(3):514-521
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN146146970&indx=1&recIds=ETOCRN146146970
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:03406245
Published in:THROMBOSIS AND HAEMOSTASIS -STUTTGART-
Language:English